Kennesaw, GA, United States of America

Hyung-Yeul Joo


 

Average Co-Inventor Count = 6.2

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Kennesaw, GA (US) (2015 - 2018)
  • Marietta, GA (US) (2021)

Company Filing History:


Years Active: 2015-2021

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Hyung-Yeul Joo in Bacterial Infection Treatment

Introduction

Hyung-Yeul Joo is a notable inventor based in Kennesaw, GA, who has made significant contributions to the field of pharmaceutical sciences. He holds three patents that focus on the development of carbapenem compounds aimed at treating bacterial infections, particularly those that are drug-resistant.

Latest Patents

One of his latest patents is titled "Carbapenem compounds and compositions for the treatment of bacterial infections." This invention provides carbapenem compounds and pharmaceutical compositions that are useful in treating bacterial infections, including those that are drug-resistant. The method involves administering an effective amount of a carbapenem compound or its salt and/or prodrug to a host in need of treatment. Another significant patent is "Carbapenem antibacterials with gram-negative activity." This invention also focuses on β-methyl carbapenem compounds and their pharmaceutical compositions for treating bacterial infections, employing similar methods of administration.

Career Highlights

Hyung-Yeul Joo is associated with Fob Synthesis, Inc., where he continues to innovate in the field of antibacterial treatments. His work is crucial in addressing the growing concern of antibiotic resistance, which poses a significant threat to public health.

Collaborations

He collaborates with talented individuals such as Woo-Baeg Choi and Ewa Gruszecka-Kowalik, contributing to a dynamic research environment that fosters innovation.

Conclusion

Hyung-Yeul Joo's contributions to the development of carbapenem compounds represent a vital advancement in the fight against bacterial infections. His work not only addresses current medical challenges but also paves the way for future innovations in antibiotic treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…